SS Innovations International Inc. (NASDAQ: SSII) has reported record second-quarter revenue of $13.9 million, a 39.4% increase year over year, signaling continued momentum for its SSi Mantra surgical robotic platform. The company's first-half revenue reached $25.0 million, up 65.6% from the same period in 2025, driven by increased system installations and growing clinical adoption.
The company installed 30 SSi Mantra systems during the quarter, a 30.4% increase, bringing the total installed base to 224 systems across 12 countries. Cumulative surgeries performed with the platform reached 12,272, reflecting growing confidence in the technology's capabilities. Gross profit for the second quarter rose 20.0% to $7.1 million, though gross margin declined to 50.9% from 59.1% in the year-earlier quarter, likely due to higher costs associated with expansion.
These results highlight the commercial traction of SSi Mantra, which is positioned as a cost-effective alternative to established robotic surgery systems. The company's focus on emerging markets, where demand for affordable surgical robotics is high, has been a key growth driver. With an installed base now spanning 12 countries, SS Innovations is establishing a global footprint that could challenge incumbents.
Looking ahead, regulatory milestones in the U.S. and Europe could serve as significant catalysts. The company is targeting FDA clearance by the first quarter of 2027 and EU CE marking by the end of 2026. Achieving these approvals would open access to two of the world's largest healthcare markets, potentially accelerating adoption and revenue growth.
telesurgery achievements are also extending the clinical profile of SSi Mantra, demonstrating its ability to perform remote procedures and expanding its utility beyond traditional operating rooms. While system installations remain the primary commercial growth driver, telesurgery capabilities differentiate the platform and could open new revenue streams.
The company's financial performance and strategic milestones underscore its position in the surgical robotics market, which is projected to grow significantly in the coming years. By focusing on affordability and innovation, SS Innovations is well-positioned to capture market share in both developed and developing regions.
Investors and industry observers will be watching for updates on regulatory progress and continued installation growth. The company's ability to execute on its strategic plan will be crucial in maintaining its upward trajectory. With a strong first half and a clear roadmap, SS Innovations is poised to build on its momentum in the second half of 2026.
